La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Effect of Ser-129 Phosphorylation on Interaction of α-Synuclein with Synaptic and Cellular Membranes*

Identifieur interne : 000561 ( Pmc/Curation ); précédent : 000560; suivant : 000562

Effect of Ser-129 Phosphorylation on Interaction of α-Synuclein with Synaptic and Cellular Membranes*

Auteurs : Naomi P. Visanji ; Sabine Wislet-Gendebien [Belgique] ; Loren W. Oschipok ; Gang Zhang ; Isabelle Aubert ; Paul E. Fraser ; Anurag Tandon [Canada]

Source :

RBID : PMC:3195582

Abstract

Background: The majority of α-synuclein is phosphorylated at serine 129 in Lewy bodies.

Results: The membrane association of PD-linked mutant α-synuclein, but not wild-type α-synuclein, was increased by serine 129 phosphorylation.

Conclusion: Pathological serine 129 phosphorylation regulates membrane accumulation of mutant α-synuclein.

Significance: The relationship of serine 129 phosphorylation to pathogenic aggregation of normal and mutant α-synuclein may be governed by distinct effects on phosphoprotein membrane accumulation.


Url:
DOI: 10.1074/jbc.M111.253450
PubMed: 21849493
PubMed Central: 3195582

Links toward previous steps (curation, corpus...)


Links to Exploration step

PMC:3195582

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Effect of Ser-129 Phosphorylation on Interaction of α-Synuclein with Synaptic and Cellular Membranes
<xref ref-type="fn" rid="FN1">*</xref>
<xref ref-type="fn" rid="FN2">
<sup>
<inline-graphic xlink:href="sbox.jpg"></inline-graphic>
</sup>
</xref>
</title>
<author>
<name sortKey="Visanji, Naomi P" sort="Visanji, Naomi P" uniqKey="Visanji N" first="Naomi P." last="Visanji">Naomi P. Visanji</name>
<affiliation>
<nlm:aff id="aff1"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Wislet Gendebien, Sabine" sort="Wislet Gendebien, Sabine" uniqKey="Wislet Gendebien S" first="Sabine" last="Wislet-Gendebien">Sabine Wislet-Gendebien</name>
<affiliation wicri:level="1">
<nlm:aff id="aff2">GIGA Neurosciences, University of Liege, 1 Avenue de l'Hôpital, 4000 Liège, Belgium,</nlm:aff>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>GIGA Neurosciences, University of Liege, 1 Avenue de l'Hôpital, 4000 Liège</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Oschipok, Loren W" sort="Oschipok, Loren W" uniqKey="Oschipok L" first="Loren W." last="Oschipok">Loren W. Oschipok</name>
<affiliation>
<nlm:aff id="aff3"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Zhang, Gang" sort="Zhang, Gang" uniqKey="Zhang G" first="Gang" last="Zhang">Gang Zhang</name>
<affiliation>
<nlm:aff id="aff1"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Aubert, Isabelle" sort="Aubert, Isabelle" uniqKey="Aubert I" first="Isabelle" last="Aubert">Isabelle Aubert</name>
<affiliation>
<nlm:aff id="aff4"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Fraser, Paul E" sort="Fraser, Paul E" uniqKey="Fraser P" first="Paul E." last="Fraser">Paul E. Fraser</name>
<affiliation>
<nlm:aff id="aff1"></nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="aff5"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Tandon, Anurag" sort="Tandon, Anurag" uniqKey="Tandon A" first="Anurag" last="Tandon">Anurag Tandon</name>
<affiliation>
<nlm:aff id="aff1"></nlm:aff>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="aff6">Medicine, University of Toronto, Toronto, Ontario M5S 1A8, Canada</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Medicine, University of Toronto, Toronto, Ontario M5S 1A8</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">21849493</idno>
<idno type="pmc">3195582</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195582</idno>
<idno type="RBID">PMC:3195582</idno>
<idno type="doi">10.1074/jbc.M111.253450</idno>
<date when="2011">2011</date>
<idno type="wicri:Area/Pmc/Corpus">000561</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000561</idno>
<idno type="wicri:Area/Pmc/Curation">000561</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000561</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">Effect of Ser-129 Phosphorylation on Interaction of α-Synuclein with Synaptic and Cellular Membranes
<xref ref-type="fn" rid="FN1">*</xref>
<xref ref-type="fn" rid="FN2">
<sup>
<inline-graphic xlink:href="sbox.jpg"></inline-graphic>
</sup>
</xref>
</title>
<author>
<name sortKey="Visanji, Naomi P" sort="Visanji, Naomi P" uniqKey="Visanji N" first="Naomi P." last="Visanji">Naomi P. Visanji</name>
<affiliation>
<nlm:aff id="aff1"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Wislet Gendebien, Sabine" sort="Wislet Gendebien, Sabine" uniqKey="Wislet Gendebien S" first="Sabine" last="Wislet-Gendebien">Sabine Wislet-Gendebien</name>
<affiliation wicri:level="1">
<nlm:aff id="aff2">GIGA Neurosciences, University of Liege, 1 Avenue de l'Hôpital, 4000 Liège, Belgium,</nlm:aff>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>GIGA Neurosciences, University of Liege, 1 Avenue de l'Hôpital, 4000 Liège</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Oschipok, Loren W" sort="Oschipok, Loren W" uniqKey="Oschipok L" first="Loren W." last="Oschipok">Loren W. Oschipok</name>
<affiliation>
<nlm:aff id="aff3"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Zhang, Gang" sort="Zhang, Gang" uniqKey="Zhang G" first="Gang" last="Zhang">Gang Zhang</name>
<affiliation>
<nlm:aff id="aff1"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Aubert, Isabelle" sort="Aubert, Isabelle" uniqKey="Aubert I" first="Isabelle" last="Aubert">Isabelle Aubert</name>
<affiliation>
<nlm:aff id="aff4"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Fraser, Paul E" sort="Fraser, Paul E" uniqKey="Fraser P" first="Paul E." last="Fraser">Paul E. Fraser</name>
<affiliation>
<nlm:aff id="aff1"></nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="aff5"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Tandon, Anurag" sort="Tandon, Anurag" uniqKey="Tandon A" first="Anurag" last="Tandon">Anurag Tandon</name>
<affiliation>
<nlm:aff id="aff1"></nlm:aff>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="aff6">Medicine, University of Toronto, Toronto, Ontario M5S 1A8, Canada</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Medicine, University of Toronto, Toronto, Ontario M5S 1A8</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series>
<title level="j">The Journal of Biological Chemistry</title>
<idno type="ISSN">0021-9258</idno>
<idno type="eISSN">1083-351X</idno>
<imprint>
<date when="2011">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>
<bold>Background:</bold>
The majority of α-synuclein is phosphorylated at serine 129 in Lewy bodies.</p>
<p>
<bold>Results:</bold>
The membrane association of PD-linked mutant α-synuclein, but not wild-type α-synuclein, was increased by serine 129 phosphorylation.</p>
<p>
<bold>Conclusion:</bold>
Pathological serine 129 phosphorylation regulates membrane accumulation of mutant α-synuclein.</p>
<p>
<bold>Significance:</bold>
The relationship of serine 129 phosphorylation to pathogenic aggregation of normal and mutant α-synuclein may be governed by distinct effects on phosphoprotein membrane accumulation.</p>
</div>
</front>
</TEI>
<pmc article-type="research-article">
<pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Biol Chem</journal-id>
<journal-id journal-id-type="hwp">jbc</journal-id>
<journal-id journal-id-type="pmc">jbc</journal-id>
<journal-id journal-id-type="publisher-id">JBC</journal-id>
<journal-title-group>
<journal-title>The Journal of Biological Chemistry</journal-title>
</journal-title-group>
<issn pub-type="ppub">0021-9258</issn>
<issn pub-type="epub">1083-351X</issn>
<publisher>
<publisher-name>American Society for Biochemistry and Molecular Biology</publisher-name>
<publisher-loc>9650 Rockville Pike, Bethesda, MD 20814, U.S.A.</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">21849493</article-id>
<article-id pub-id-type="pmc">3195582</article-id>
<article-id pub-id-type="publisher-id">M111.253450</article-id>
<article-id pub-id-type="doi">10.1074/jbc.M111.253450</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Molecular Bases of Disease</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Effect of Ser-129 Phosphorylation on Interaction of α-Synuclein with Synaptic and Cellular Membranes
<xref ref-type="fn" rid="FN1">*</xref>
<xref ref-type="fn" rid="FN2">
<sup>
<inline-graphic xlink:href="sbox.jpg"></inline-graphic>
</sup>
</xref>
</article-title>
<alt-title alt-title-type="short">Ser-129 Phosphorylation and Membrane Binding of α-Synuclein</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Visanji</surname>
<given-names>Naomi P.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup></sup>
</xref>
<xref ref-type="author-notes" rid="FN3">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="FN4">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wislet-Gendebien</surname>
<given-names>Sabine</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>§</sup>
</xref>
<xref ref-type="author-notes" rid="FN3">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="FN5">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Oschipok</surname>
<given-names>Loren W.</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup></sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Gang</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup></sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Aubert</surname>
<given-names>Isabelle</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup></sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fraser</surname>
<given-names>Paul E.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup></sup>
</xref>
<xref ref-type="aff" rid="aff5">**</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tandon</surname>
<given-names>Anurag</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup></sup>
</xref>
<xref ref-type="aff" rid="aff6">
<sup>‡‡</sup>
</xref>
<xref ref-type="corresp" rid="cor1">
<sup>4</sup>
</xref>
</contrib>
<aff id="aff1">From the
<label></label>
Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Ontario M5S 3H2, Canada,</aff>
<aff id="aff2">
<label>§</label>
GIGA Neurosciences, University of Liege, 1 Avenue de l'Hôpital, 4000 Liège, Belgium,</aff>
<aff id="aff3">the
<label></label>
Brain Research Centre, University of British Columbia, British Columbia V6T 2B5, Canada,</aff>
<aff id="aff4">the
<label></label>
Sunnybrook Research Institute and Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario M4N 3M5, Canada, and</aff>
<aff id="aff5">the Departments of
<label>**</label>
Medical Biophysics and</aff>
<aff id="aff6">
<label>‡‡</label>
Medicine, University of Toronto, Toronto, Ontario M5S 1A8, Canada</aff>
</contrib-group>
<author-notes>
<corresp id="cor1">
<label>4</label>
To whom correspondence should be addressed:
<addr-line>Centre for Research in Neurodegenerative Diseases, University of Toronto, 6 Queen's Park Crescent West, Toronto, Ontario M5S 3H2, Canada.</addr-line>
Tel.:
<phone>416-978-8880</phone>
; Fax:
<fax>416-978-1878</fax>
; E-mail:
<email>a.tandon@utoronto.ca</email>
.</corresp>
<fn fn-type="equal" id="FN3">
<label>1</label>
<p>Both authors contributed equally to this work.</p>
</fn>
<fn fn-type="supported-by" id="FN4">
<label>2</label>
<p>Supported by a fellowship from the Parkinson Society of Canada.</p>
</fn>
<fn fn-type="supported-by" id="FN5">
<label>3</label>
<p>Supported by a fellowship from the Canadian Institutes of Health Research.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<day>14</day>
<month>10</month>
<year>2011</year>
</pub-date>
<pub-date pub-type="epub">
<day>17</day>
<month>8</month>
<year>2011</year>
</pub-date>
<volume>286</volume>
<issue>41</issue>
<fpage>35863</fpage>
<lpage>35873</lpage>
<history>
<date date-type="received">
<day>20</day>
<month>4</month>
<year>2011</year>
</date>
<date date-type="rev-recd">
<day>11</day>
<month>8</month>
<year>2011</year>
</date>
</history>
<permissions>
<copyright-statement>© 2011 by The American Society for Biochemistry and Molecular Biology, Inc.</copyright-statement>
<copyright-year>2011</copyright-year>
</permissions>
<self-uri xlink:title="pdf" xlink:type="simple" xlink:href="zbc04111035863.pdf"></self-uri>
<abstract abstract-type="teaser">
<p>
<bold>Background:</bold>
The majority of α-synuclein is phosphorylated at serine 129 in Lewy bodies.</p>
<p>
<bold>Results:</bold>
The membrane association of PD-linked mutant α-synuclein, but not wild-type α-synuclein, was increased by serine 129 phosphorylation.</p>
<p>
<bold>Conclusion:</bold>
Pathological serine 129 phosphorylation regulates membrane accumulation of mutant α-synuclein.</p>
<p>
<bold>Significance:</bold>
The relationship of serine 129 phosphorylation to pathogenic aggregation of normal and mutant α-synuclein may be governed by distinct effects on phosphoprotein membrane accumulation.</p>
</abstract>
<abstract>
<p>In the healthy brain, less than 5% of α-synuclein (α-syn) is phosphorylated at serine 129 (Ser(P)-129). However, within Parkinson disease (PD) Lewy bodies, 89% of α-syn is Ser(P)-129. The effects of Ser(P)-129 modification on α-syn distribution and solubility are poorly understood. As α-syn normally exists in both membrane-bound and cytosolic compartments, we examined the binding and dissociation of Ser(P)-129 α-syn and analyzed the effects of manipulating Ser(P)-129 levels on α-syn membrane interactions using synaptosomal membranes and neural precursor cells from α-syn-deficient mice or transgenic mice expressing human α-syn. We first evaluated the recovery of the Ser(P)-129 epitope following either α-syn membrane binding or dissociation. We demonstrate a rapid turnover of Ser(P)-129 during both binding to and dissociation from synaptic membranes. Although the membrane binding of WT α-syn was insensitive to modulation of Ser(P)-129 levels by multiple strategies (the use of phosphomimic S129D and nonphosphorylated S129A α-syn mutants; by enzymatic dephosphorylation of Ser(P)-129 or proteasome inhibitor-induced elevation in Ser(P)-129; or by inhibition or stable overexpression of PLK2), PD mutant Ser(P)-129 α-syn showed a preferential membrane association compared with WT Ser(P)-129 α-syn. Collectively, these data suggest that phosphorylation at Ser-129 is dynamic and that the subcellular distribution of α-syn bearing PD-linked mutations, A30P or A53T, is influenced by the phosphorylation state of Ser-129.</p>
</abstract>
<kwd-group>
<kwd>Neurodegeneration</kwd>
<kwd>Parkinson Disease</kwd>
<kwd>Phosphatase</kwd>
<kwd>Post-translational Modification</kwd>
<kwd>Protein Phosphorylation</kwd>
<kwd>Subcellular Fractionation</kwd>
<kwd>Synuclein</kwd>
<kwd>Kinase</kwd>
<kwd>Membrane Binding</kwd>
<kwd>Synaptosome</kwd>
</kwd-group>
</article-meta>
</front>
</pmc>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Pmc/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000561 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Pmc/Curation/biblio.hfd -nk 000561 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Pmc
   |étape=   Curation
   |type=    RBID
   |clé=     PMC:3195582
   |texte=   Effect of Ser-129 Phosphorylation on Interaction of α-Synuclein with Synaptic and Cellular Membranes*
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Curation/RBID.i   -Sk "pubmed:21849493" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a ParkinsonCanadaV1 

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022